Genero, C. Canepa, H. F. Gomez, and T. G. Cleary. 1995. Tumor necrosis
factor concentrations in hemolytic uremic syndrome patients and children 32.
with bloody diarrhea in Argentina. Pediatr. Infect. Dis. J. 14:594–598.
20. Louise, C. B., and T. G. Obrig. 1992. Shiga toxin-associated hemolytic- 33.
uremic syndrome: combined cytotoxic effect of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Im- mun. 60:1536–1543. 34.
21. Louise, C. B., and T. G. Obrig. 1991. Shiga toxin-associated hemolyticuremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1ß,
and tumor necrosis factor alpha on human vascular endothelial cells in vitro. 35.
Infect. Immun. 59:4173–4179.
22. Mariani-Kurkdjian, P., and E. Bingen. 1995. Hemolytic-uremic syndrome
after verotoxin-producing Escherichia coli infection. Presse Med. 24:99–101. 36.
23. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival;
application to proliferation and cytotoxicity assays. J. Immunol. Methods
65:55–63.
24. Newburg, D. S., and P. Chaturvedi. 1992. Neutral glycolipids of human and
37.
bovine milk. Lipids 27:923–927.
25. Newburg, D. S., P. Chaturvedi, E. L. Lopez, S. Devoto, A. Gayad, and T. G.
Cleary. 1993. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. J. Infect. Dis. 168:476–479.
26. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney, and
T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and 38.
responses. J. Biol. Chem. 268:15484–15488.
27. Ohlmann, D., G. F. Hamann, M. Hassler, and K. Schimrigk. 1996. Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Nervenarzt 67:880–882.
28. Pardridge, W. M. 1988. Recent advances in blood-brain barrier transport. 39.
Annu. Rev. Pharmacol. Toxicol. 28:25–39.
29. Pellizzari, A., H. Pang, and C. A. Lingwood. 1992. Binding of verocytotoxin
1 to its receptor is influenced by differences in receptor fatty acid content. 40.
Biochemistry 31:1363–1370.
30. Prado, D., T. G. Cleary, L. K. Pickering, C. D. Ericsson, A. V. Bartlett,
H. L. DuPont, and P. C. Johnson. 1986. The relation between production of 41.
cytotoxin and clinical features in shigellosis. J. Infect. Dis. 154:149–155.
31. Ramegowda, B., J. E. Samuel, and V. L. Tesh. 1999. Interaction of Shiga
toxins with human brain microvascular endothelial cells: cytokines as sensi-
